Assessment of age‐related maculopathy using subjective vision tests

REFERENCES

• Kitchin JE. Assessment of visual functions of patients with senile macular degeneration. Aust J Optom 1981; 64: 176–183.
   Google Scholar
• Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G., Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R. et al. An international classification and grading system for age‐related maculopathy and age‐related macular degeneration. The international ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367–374.
   PubMed Web of Science ®Google Scholar
• Bird AC, Barnes RM. Age‐related macular disease: an ongoing challenge. Clin Exp Ophthalmol 2003; 31: 461–463.
   PubMed Web of Science ®Google Scholar
• Fine SL. Age‐related macular degeneration 1969–2004: a 35‐year personal perspective. Am J Ophthalmol 2005; 139: 405–420.
   PubMed Web of Science ®Google Scholar
• Mitchell P., Smith W., Attebo K., Wang JJ. Prevalence of age‐related maculopathy in Australia: The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450–1460.
   PubMed Web of Science ®Google Scholar
• Vannewkirk MR, Nanjan MB, Wang JJ, Mitchell P., Taylor HR, Mccarty CA. The prevalence of age‐related maculopathy: the visual impairment project. Ophthalmology 2000; 107: 1593–1600.
   PubMed Web of Science ®Google Scholar
• Congdon N., O'colmain B., Klaver CCW, Klein R., Munoz B., Friedman DS, Kempen J., Taylor HR, Mitchell P., Eye Disease Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477–485.
   PubMed Web of Science ®Google Scholar
• Evans JR, Fletcher AE, Wormald RPL. Causes of visual impairment in people aged 75 years and older in Britain: an add‐on study to the MRC Trial of Assessment and Management of Older People in the Community. Br J Ophthalmol 2004; 88: 365–370.
   PubMed Web of Science ®Google Scholar
• Friedman DS, O'colmain BJ, Munoz B., Tomany SC, Mccarty C., de Jong PT, Memesure B., Kempen J., Eye Diseases Prevalence Research Group. Prevalence of age‐related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564–572.
   PubMed Web of Science ®Google Scholar
• Taylor H., Keeffe J., Vu H., Wang J., Rochtchina E., Pezzullo M., Mitchell P.. Vision loss in Australia. MJA 2005; 182: 565–568.
   PubMed Web of Science ®Google Scholar
• Evans J., Wormald R.. Is the incidence of registrable age‐related macular degeneration increasing Br J Ophthalmol 1996; 80: 9–14.
   PubMed Web of Science ®Google Scholar
• Mukesh BN, Dimitrov PN, Leikin S., Wang JJ, Mitchell P., Mccarty CA, Taylor HR. Five‐year incidence of age‐related maculopathy: The Visual Impairment Project. Ophthalmology 2004; 111: 1176–1182.
   PubMed Web of Science ®Google Scholar
• Mitchell P., Wang JJ, Foran S., Smith W.. Five‐year incidence of age‐related maculopathy lesions: The Blue Mountains Eye Study. Ophthalmology 2002; 109: 1092–1097.
   PubMed Web of Science ®Google Scholar
• Wright SE, Keeffe JE, Thies LS. Direct costs of blindness in Australia. Clin Exp Ophthalmol 2000; 28: 140–142.
   PubMed Web of Science ®Google Scholar
• Bonastre J., Le Pen C., Anderson P., Ganz A., Berto P., Berdeaux G.. The epidemiology, economics and quality of life burden of age‐related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ 2002; 3: 94–102.
   PubMedGoogle Scholar
• Owen CG, Fletcher AE, Donoghue M., Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom Br J Ophthalmol 2003; 87: 312–317.
   PubMed Web of Science ®Google Scholar
• Hopley C., Salkeld G., Mitchell P.. Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration. Br J Ophthalmol 2004; 88: 982–987.
   PubMed Web of Science ®Google Scholar
• Davis CA, Lovie‐kitchin JE, Thompson B.. Psychosocial adjustment to age‐related macular degeneration. J Vis Impair Blindness 1995; 89: 16–27.
   Web of Science ®Google Scholar
• Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998; 116: 514–520.
   PubMed Web of Science ®Google Scholar
• Decarlo DK, Scilley K., Wells J., Owsley C.. Driving habits and health‐related quality of life in patients with age‐related maculopathy. Optom Vis Sci 2003; 80: 207–213.
   PubMed Web of Science ®Google Scholar
• Stevenson MR, Hart PM, Montgomery A‐M, Mcculloch DW, Chakravarthy U.. Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. Br J Ophthalmol 2004; 88: 1125–1130.
   PubMed Web of Science ®Google Scholar
• Lamoureux EL, Hassell JB, Keeffe JE. The determinants of participation in activities of daily living in people with impaired vision. Am J Ophthalmol 2004; 137: 265–270.
   PubMed Web of Science ®Google Scholar
• Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision‐related quality of life in patients with bilateral severe age‐related macular degeneration. Ophthalmology. 2005; 112: 152–158.
   PubMed Web of Science ®Google Scholar
• Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age‐related macular degeneration with verteporfin: two‐year results of two randomized clinical trials—TAP report 2. Arch Ophthalmol 2001; 119: 198–207.
   PubMed Web of Science ®Google Scholar
• Bressler NM, Arnold J., Benchaboune M., Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H., Schmidt‐erfurth U., Slakter JS, Bressler SB, Manos K., Hao Y., Hayes L., Koester J., Reaves A., Strong HA; Treatment of Age‐Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age‐related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes—TAP report No. 3. Arch Ophthalmol 2002; 120: 1443–1454.
   PubMedGoogle Scholar
• Armbrecht AM, Aspinall PA, Dhillon B.. A prospective study of visual function and quality of life following PDT in patients with wet age‐related macular degeneration. Br J Ophthalmol 2004; 88: 1270–1273.
   PubMed Web of Science ®Google Scholar
• Krummenauer F., Braun M., Dick HB. Clinical outcome and subjective quality of life after photodynamic therapy in patients with age‐related macular degeneration. Eur J Ophthalmol 2005; 15: 74–80.
   Web of Science ®Google Scholar
• Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age‐related macular degeneration: Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991; 109: 1242–1257.
   PubMed Web of Science ®Google Scholar
• Hopley C., Salkeld G., Wang JJ, Mitchell P.. Cost utility of screening and treatment for early age‐related macular degeneration with zinc and antioxidants. Br J Ophthalmol 2004; 88: 450–454.
   PubMed Web of Science ®Google Scholar
• Age‐Related Eye Disease Study Research Group. A randomized, placebo‐controlled, clinical trial of high‐dose supplementation with vitamins C and E, beta carotene and zinc for age‐related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417–1436.
   PubMed Web of Science ®Google Scholar
• Haegerstrom‐portnoy G., Schneck M., Brabyn J.. Seeing into old age: Vision function beyond acuity. Optom Vis Sci 1999; 76: 141–158.
   PubMed Web of Science ®Google Scholar
• Ivers RQ, Mitchell P., Cumming RG. Visual function tests, eye disease and symptoms of visual disability: a population‐based assessment. Clin Exp Ophthalmol 2000; 28: 41–47.
   PubMed Web of Science ®Google Scholar
• Haegerstrom‐portnoy G.. The Glenn A. Fry Award Lecture 2003: Vision in elders—summary of findings of the SKI study. Optom Vis Sci 2005; 82: 87–93.
   PubMed Web of Science ®Google Scholar
• Eisner A., Fleming SA, Klein ML, Mauldin M.. Sensitivities in older eyes with good acuity: Eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci 1987; 28: 1832–1837.
   PubMed Web of Science ®Google Scholar
• Brown B., Lovie‐kitchin J.. Dark adaptation and acuity/luminance response in senile macular degeneration. Am J Optom Physiol Opt 1983; 60: 645–650.
   PubMedGoogle Scholar
• Brown B., Lovie‐kitchin JE. Contrast sensitivity in the central and paracentral retina in age related maculopathy. Clin Exp Optom 1987; 70: 145–148.
   Google Scholar
• Gerth C., Hauser D., Delahunt PB, Morse LS, Werner JS. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol 2003; 121: 1404–1414.
   PubMedGoogle Scholar
• Hart WM, Burde RM. Three‐dimensional topography of the central visual field. Sparing of foveal sensitivity in macular disease. Ophthalmology 1983; 90: 1028–1038.
   Web of Science ®Google Scholar
• Swann PG, Lovie‐kitchin JE. Age‐related maculopathy: II. The nature of the central visual field loss. Ophthalmic Physiol Opt 1991; 11: 59–70.
   PubMed Web of Science ®Google Scholar
• Cheng AS, Vingrys AJ. Visual losses in early age‐related maculopathy. Optom Vis Sci 1993; 70: 89–96.
   Web of Science ®Google Scholar
• Tolentino MJ, Miller S., Gaudio AR, Sandberg MA. Visual field deficits in early age‐related macular degeneration. Vision Res 1994; 34: 409–413.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Mederios NE, Millican CL. Photoreceptor loss in age‐related macular degeneration. Invest Ophthalmol Vis Sci 1996; 37: 1236–1249.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Owsley C., Jackson GR. Spare the rods, save the cones in aging and age‐related maculopathy. Invest Ophthalmol Vis Sci 2000; 41: 2015–2018.
   PubMed Web of Science ®Google Scholar
• Wang Q., Chappell RJ, Klein R., Eisner A., Klien BEK, Jensen SC, Moss SE. Pattern of age‐related maculopathy in the macular area. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1996; 37: 2234–2242.
   Google Scholar
• Bowman KJ. The clinical assessment of colour discrimination in senile macular degeneration. Acta Ophthalmol Scand 1980; 58: 337–346.
   Google Scholar
• Bowman KJ, Cameron KD. A quantitative assessment of colour discrimination in normal vision and senile macular degeneration using some colour confusion tests. Doc Ophthalmol Proc Series 1984; 39: 363–370.
   Google Scholar
• Collins MJ. Pre‐age related maculopathy and the desaturated D‐15 colour vision test. Clin Exp Optom 1986; 69: 223–227.
   Google Scholar
• Applegate RA, Adams AJ, Cavender J., Zisman F.. Early color vision changes in age‐related maculopathy. Appl Opt 1987; 26: 1458–1462.
   Web of Science ®Google Scholar
• Collins M., Brown B.. Glare recovery and its relation to other clinical findings in age related maculopathy. Clin Vis Sci 1989; 4: 155–163.
   Google Scholar
• Sunness JS, Massof RW, Bressler NM, Bressler SB. S‐cone pathway sensitivities in eyes with high risk and low risk drusen characteristics. Appl Opt 1989; 28: 1158–1164.
   Web of Science ®Google Scholar
• Haegerstrom‐portnoy G., Brown B.. Two‐color increment thresholds in early age‐related maculopathy. Clin Vis Sci 1989; 4: 165–172.
   Google Scholar
• Eisner A., Klein ML, Zilis JD, Watkins MD. Visual function and the subsequent development of exudative age‐related macular degeneration. Invest Ophthalmol Vis Sci 1992; 33: 3091–3102.
   PubMed Web of Science ®Google Scholar
• Feigl B., Brown B., Lovie‐kitchin J., Swann P.. Cone‐mediated multifocal electroretinogram in early age‐related maculopathy and its relationships with subjective macular function tests. Curr Eye Res 2004; 29: 327–336.
   PubMed Web of Science ®Google Scholar
• Smith VC, Pokorny J., Diddie KR. Color matching and the Stiles‐Crawford effect in observers with early age‐related macular changes. J Opt Soc Am A 1988; 5: 2113–2121.
   Google Scholar
• Eisner A., Fleming SA, Klein ML, Mauldin M.. Sensitivities in older eyes with good acuity: Cross‐sectional norms. Invest Ophthalmol Vis Sci 1987; 28: 1824–1831.
   PubMed Web of Science ®Google Scholar
• Eisner A., Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age‐related macular degeneration. Invest Ophthalmol Vis Sci 1991; 32: 8–20.
   PubMed Web of Science ®Google Scholar
• Sjostrand J.. Contrast sensitivity in macular disease using a small‐field and a large‐field TV‐system. Acta Ophthalmol Scand 1979; 57: 832–846.
   Google Scholar
• Kleiner RC, Enger C., Alexander MF, Fine SL. Contrast sensitivity in age‐related macular degeneration. Arch Ophthalmol 1988; 106: 55–57.
   PubMedGoogle Scholar
• Owsley C., Sloane ME, Skalka HW, Jackson CA. A comparison of the Regan low‐contrast letter charts and contrast sensitivity testing in older patients. Clin Vis Sci 1990; 5: 325–334.
   Google Scholar
• Frennesson C., Nilsson UL, Nilsson SE. Colour contrast sensitivity in patients with soft drusen, an early stage of ARM. Doc Ophthalmol 1995; 90: 377–386.
   PubMed Web of Science ®Google Scholar
• Midena E., Angeli CD, Blarzino MC, Valenti M., Segato T.. Macular function impairment in eyes with early age‐related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38: 469–477.
   PubMed Web of Science ®Google Scholar
• Phipps JA, Guymer RH, Vingrys AJ. Temporal sensitivity deficits in patients with high‐risk drusen. Aust NZ J Ophthalmol 1999; 27: 265–267.
   Google Scholar
• Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age‐related maculopathy. Invest Ophthalmol Vis Sci 2003; 44: 2277–2283.
   Web of Science ®Google Scholar
• Arden GB, Wolf JE. Colour vision testing as an aid to diagnosis and management of age‐related maculopathy. Br J Ophthalmol 2004; 88: 1180–1185.
   PubMed Web of Science ®Google Scholar
• Midena E., Segato T., Blarzino MC, Angeli CD. Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol 1994; 88: 179–185.
   PubMed Web of Science ®Google Scholar
• Sheu S‐J, Chen Y‐Y, Chou L‐C, Wu T‐T, Cheng K‐K. Frequency doubling technology perimetry in age‐related macular degeneration. Zhonghua Yi Xue Za Zhi (Chinese Medical Journal) 2002; 65: 435–440.
   Google Scholar
• Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2004; 45: 3355–3360.
   PubMed Web of Science ®Google Scholar
• Goldstein M., Loewenstein A., Barak A., Pollack A., Bukelman A., Katz H., Springer A., Schachat AP, Bressler NM, Bressler B., Cooney MJ, Alster Y., Rafaeli O., Malach R., Preferential Hyperacuity Perimeter Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age‐related macular degeneration. Retina 2005; 25: 296–303.
   PubMed Web of Science ®Google Scholar
• Brown B., Tobin C., Roche N., Wolanowski A.. Cone adaptation in age‐related maculopathy. Am J Optom Physiol Opt 1986; 63: 450–454.
   PubMedGoogle Scholar
• Collins M., Brown B.. Glare recovery and age‐related maculopathy. Clin Vis Sci 1989; 4: 145–153.
   Google Scholar
• Brown B., Lovie‐kitchin J.. Temporal summation in age‐related maculopathy. Optom Vis Sci 1989; 66: 426–429.
   Web of Science ®Google Scholar
• Sandberg MA, Gaudio AR. Slow photostress recovery and disease severity in age‐related macular degeneration. Retina 1995; 15: 407–412.
   PubMed Web of Science ®Google Scholar
• Sandberg MA, Weiner A., Miller S., Gaudio AR. High‐risk characteristics of fellow eyes of patients with unilateral neovascular age‐related macular degeneration. Ophthalmology 1998; 105: 441–447.
   Web of Science ®Google Scholar
• Owsley C., Jackson GR, Cideciyan AV, Huang Y., Fine SL, Ho AC, Maguire MG, Lolley V., Jacobson SG. Psychophysical evidence for rod vulnerability in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41: 267–273.
   PubMed Web of Science ®Google Scholar
• Sunness JS, Johnson MA, Massof RW, Marcus S.. Retinal sensitivity over drusen and nondrusen areas: A study using fundus perimetry. Arch Ophthalmol 1988; 106: 1081–1084.
   PubMedGoogle Scholar
• Sunness JS, Massof RW, Johnson MA, Bressler NM, Bressler SB, Fine SL. Diminished foveal sensitivity may predict the development of advanced age‐related macular degeneration. Ophthalmology 1989; 96: 375–380.
   Web of Science ®Google Scholar
• Massof RW, Choy D., Sunness JS, Johnson MA, Rubin GS, Fine SL. Foveal threshold elevations associated with age‐related drusen. Clin Vis Sci 1989; 4: 221–227.
   Google Scholar
• Mayer MJ, Spiegler SJ, Ward B., Glucs A., Kim CB. Preliminary evaluation of flicker sensitivity as a predictive test for exudative age‐related maculopathy. Invest Ophthalmol Vis Sci 1992; 33: 3150–3155.
   PubMed Web of Science ®Google Scholar
• Mayer MJ, Spiegler SJ, Ward B., Glucs A., Kim CB. Mid‐frequency loss of foveal flicker sensitivity in early stages of age‐related maculopathy. Invest Ophthalmol Vis Sci 1992; 33: 3136–3142.
   Web of Science ®Google Scholar
• Mayer MJ, Spiegler SJ, Ward B., Glucs A., Kim CB. Foveal flicker sensitivity discriminates ARM‐risk from healthy eyes. Invest Ophthalmol Vis Sci 1992; 33: 3143–3149.
   PubMed Web of Science ®Google Scholar
• Mayer MJ, Ward B., Klein R., Talcott JB, Dougherty RF, Glucs A.. Flicker sensitivity and fundus appearance in pre‐exudative age‐related maculopathy. Invest Ophthalmol Vis Sci 1994; 35: 1138–1149.
   Web of Science ®Google Scholar
• Remky A., Lichtenberg K., Elsner AE, Arend O.. Short wavelength automated perimetry in age‐related maculopathy. Br J Ophthalmol 2001; 85: 1432–1436.
   Web of Science ®Google Scholar
• Remky A., Elsner AE. Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age‐related macular disease. Br J Ophthalmol 2005; 89: 464–469.
   Web of Science ®Google Scholar
• Lovie‐kitchin JE, Bowman KJ. Senile Macular Degeneration—Management and Rehabilitation. Boston: Butterworths; 1985.
   Google Scholar
• Greeves AL, Cole BL. Assessment of contrast sensitivity of patients with macular disease using reduced contrast near visual acuity charts. Ophthalmic Physiol Opt 1988; 8: 371–377.
   PubMed Web of Science ®Google Scholar
• Lovie‐kitchin JE. High contrast and low contrast visual acuity in age‐related macular degeneration. Clin Exp Optom 1989; 72: 79–83.
   Google Scholar
• Brown B., Lovie‐kitchin J.. High and low contrast acuity, and clinical contrast sensitivity tested in a normal population. Optom Vis Sci 1989; 66: 467–473.
   PubMed Web of Science ®Google Scholar
• Abadi RV, Pantazidou M.. Low contrast letter acuity in age‐related maculopathy. Ophthalmic Physiol Opt 1996; 16: 455–459.
   Web of Science ®Google Scholar
• Schneck ME, Haegerstrom‐portnoy G., Lott LA, Brabyn JA, Gildengorin G.. Low contrast vision function predicts subsequent acuity loss in an aged population: the SKI study. Vision Res 2004; 44: 2317–2325.
   PubMed Web of Science ®Google Scholar
• Brown B., Adams AJ, Coletta NJ, Haegerstrom‐portnoy G.. Dark adaptation in age‐related maculopathy. Ophthalmic Physiol Opt 1986; 6: 81–84.
   PubMed Web of Science ®Google Scholar
• Eisner A.. Losses of flicker sensitivity during dark adaptation: effects of test size and wavelength. Vision Res 1992; 32: 1975–1986.
   Web of Science ®Google Scholar
• Steinmetz RL, Haimovici R., Jubb C., Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age‐related Bruch's membrane change. Br J Ophthalmol 1993; 77: 549–554.
   PubMed Web of Science ®Google Scholar
• Owsley C., Jackson GR, White M., Feist R., Edwards D.. Delays in rod‐mediated dark adaptation in early age‐related maculopathy. Ophthalmology 2001; 108: 1196–1202.
   PubMed Web of Science ®Google Scholar
• Haimovici R., Owens SL, Fitzke FW, Bird AC. Dark adaptation in age‐related macular degeneration: relationship to the fellow eye. Graefe's Arch Clin Exp Ophthalmol 2002; 240: 90–95.
   PubMed Web of Science ®Google Scholar
• Sunness JS. Evaluating macular function. Int Ophthalmol Clin 1999; 39: 19–31.
   Google Scholar
• Richer S.. A protocol for the evaluation and treatment of atrophic age‐related macular degeneration. J Am Optom Assoc 1999; 70: 13–23.
   Google Scholar
• Vingrys AJ. Research into macular degeneration provides better ways to assess its prognosis. Clin Exp Optom 2004; 87: 63–64.
   Google Scholar
• Brown B., Lovie‐kitchin JE. Repeated visual acuity measurement: Establishing the patient's own criterion for change. Optom Vis Sci 1993; 70: 45–53.
   PubMed Web of Science ®Google Scholar
• Haegerstrom‐portnoy G., Schneck ME, Lott LA, Brabyn JA. The relation between visual acuity and other spatial vision measures. Optom Vis Sci 2000; 77: 653–662.
   PubMed Web of Science ®Google Scholar
• Haegerstrom‐portnoy G., Brabyn J., Schneck ME, Jampolsky A.. The SKILL Card: An acuity test of reduced luminance and contrast. Invest Ophthalmol Vis Sci 1997; 38: 207–218.
   PubMed Web of Science ®Google Scholar
• Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt 1976; 53: 740–745.
   PubMedGoogle Scholar
• Rubin GS, West SK, Munoz B., Bandeen‐roche K., Zeger S., Schein O., Fried LP. A comprehensive assessment of visual impairment in a population of older Americans. The SEE study. Invest Ophthalmol Vis Sci 1997; 38: 557–568.
   PubMed Web of Science ®Google Scholar
• Bowman KJ. The relationship between colour discrimination and visual acuity in senile macular degeneration. Am J Optom Physiol Opt 1980; 57: 145–148.
   Google Scholar
• Mckendrick AM. Recent developments in perimetry: test stimuli and procedures. Clin Exp Optom 2005; 88: 73–80.
   PubMedGoogle Scholar
• Wood J., Swann P., Stavrou E.. Visual fields in glaucoma: a clinical overview. Clin Exp Optom 2000; 83: 128–135.
   Google Scholar
• Severin SL, Tour RL, Kershaw RH. Macular function and the photostress test 1. Arch Ophthalmol 1967; 77: 2–7.
   PubMedGoogle Scholar
• Glaser JS, Savino PJ, Sumers KD, Mcdonald SA, Knighton RW. The photo‐stress recovery test in the clinical assessment of visual function. Am J Ophthalmol 1977; 83: 255–260.
   PubMed Web of Science ®Google Scholar
• Bailey IL, Bullimore MA. A new test for the evaluation of disability glare. Optom Vis Sci 1991; 68: 911–917.
   PubMed Web of Science ®Google Scholar
• Jackson GR, Owsley C., Mcgwin G. Jr. Aging and dark adaptation. Vision Res 1999; 39: 3975–3982.
   PubMed Web of Science ®Google Scholar
• Lovie‐kitchin JE, Whittaker SG. Prescribing near magnification for low vision patients. Clin Exp Optom 1999; 82: 214–224.
   PubMedGoogle Scholar
• Lovie‐kitchin J., Devereaux J., Wells S., Sculpher K‐A. Multi‐disciplinary low vision care. Clin Exp Optom 2001; 84: 165–170.
   Google Scholar
• Lott LA, Schneck ME, Haegerstrom‐portnoy G., Brabyn JA, Gildengorin GL, West CG. Reading performance in older adults with good acuity. Optom Vis Sci 2001; 78: 316–324.
   PubMed Web of Science ®Google Scholar
• Rubin GS, Roche KB, Prasada‐rao P., Fried LP. Visual impairment and disability in older adults. Optom Vis Sci 1994; 71: 750–760.
   PubMed Web of Science ®Google Scholar
• Bailey IL, Lovie JE. The design and use of a new near‐vision chart. Am J Optom Physiol Opt 1980; 57: 378–387.
   PubMedGoogle Scholar
• Ahn SJ, Legge GE, Luebker A.. Printed cards for measuring low‐vision reading speed. Vision Res 1995; 35: 1939–1944.
   Web of Science ®Google Scholar
• Lovie‐kitchin J., Whittaker S.. Prescribing magnification for reading with low vision: What are the criteria? In: Stuen C., Arditi A., Horowitz A., Lang M., Rosenthal B., Seidman K., eds. Vision Rehabilitation—Assessment, Intervention and Outcomes. Lisse: Swets & Zeitlinger, 2000. p. 314–318.
   Google Scholar
• Legge GE, Ross JA, Isenberg LM, Lamay JM. Psychophysics of reading: Clinical predictors of low vision reading speed. Invest Ophthalmol Vis Sci 1992; 33: 677–687.
   Web of Science ®Google Scholar
• Whittaker SG, Lovie‐kitchin JE. Visual requirements for reading. Optom Vis Sci 1993; 70: 54–65.
   PubMed Web of Science ®Google Scholar
• Stangos N., Voutas S., Topouzis F., Karampatakis V.. Contrast sensitivity evaluation in eyes predisposed to age‐related macular degeneration and presenting normal visual acuity. Ophthalmologica 1995; 209: 194–198.
   PubMed Web of Science ®Google Scholar
• Verbaken JH, Johnston AW. Population norms for edge contrast sensitivity. Am J Optom Physiol Opt 1986; 63: 724–732.
   PubMedGoogle Scholar
• Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 1988; 2: 187–199.
   Google Scholar
• Arditi A.. Improving the design of the letter contrast sensitivity test. Invest Ophthalmol Vis Sci 2005; 46: 2225–2229.
   PubMed Web of Science ®Google Scholar
• Schuchard RA. Validity and interpretation of Amsler grid reports. Arch Ophthalmol 1993; 111: 776–780.
   Google Scholar
• Zaidi FH, Cheong‐leen R., Gair EJ, Weir R., Sharkawi E., Lee N., Gregory‐evans K.. The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey. Eye 2004; 18: 503–508.
   Web of Science ®Google Scholar
• Hammond BR Jr, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age‐related macular degeneration. Vision Res 1996; 36: 3003–3009.
   PubMed Web of Science ®Google Scholar
• Tomany SC, Wang JJ, Van Leeuwen R., Klein R., Mitchell P., Vingerling JR, Klein BE, Smith W., de Jong PT. Risk factors for incident age‐related macular degeneration: pooled findings from three continents. Ophthalmology 2004; 111: 1280–1287.
   PubMed Web of Science ®Google Scholar
• Jakobsdottir J., Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age‐related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389–407.
   PubMed Web of Science ®Google Scholar
• Clemons TE, Milton RC, Klein R., Seddon JM, Ferris FL 3rd. Risk factors for the incidence of advanced age‐related macular degeneration in the Age‐Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005; 112: 533–539.
   PubMed Web of Science ®Google Scholar
• Bullimore MA. Editorial—Who's on first Optom Vis Sci 2000; 77: 333–334.
   Web of Science ®Google Scholar
• Lovie‐kitchin J., Bailey IL. Visual acuity measurement: 20 years on from the Bailey‐Lovie chart. In: Vision 1996, Book 1, Proceedings of the International Conference on Low Vision 1996. Madrid: Organización Nacional de Ciegos Españoles, 1998. p. 45–49.
   Google Scholar
• Brown B., Yap MKH. Differences in visual acuity between the eyes: Determination of normal limits in a clinical population. Ophthalmic Physiol Opt 1995; 15: 163–169.
   Web of Science ®Google Scholar
• Bailey IL, Bullimore MA, Raasch TW, Taylor HR. Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci 1991; 32: 422–432.
   PubMed Web of Science ®Google Scholar
• Kuyk T., Elliott JL. Visual factors and mobility in persons with age‐related macular degeneration. J Rehab Res Development 1999; 36: 303–312.
   PubMed Web of Science ®Google Scholar
• Hassan S., Lovie‐kitchin J., Woods R.. Vision and mobility performance of subjects with age‐related macular degeneration. Optom Vis Sci 2002; 79: 697–707.
   PubMed Web of Science ®Google Scholar
• Bullimore MA, Bailey IL, Wacker RT. Face recognition in age‐related maculopathy. Invest Ophthalmol Vis Sci 1991; 32: 2020–2029.
   PubMed Web of Science ®Google Scholar
• Legge GE, Rubin GS, Pelli DG, Schleske MM. Psychophysics of reading—II. Low vision. Vision Res 1985; 25: 253–266.
   PubMed Web of Science ®Google Scholar
• Lovie‐kitchin J., Bowers A., Woods R.. Oral and silent reading performance with macular degeneration. Ophthalmic Physiol Opt 2000; 20: 360–370.
   PubMed Web of Science ®Google Scholar
• Bowers A., Lovie‐kitchin J., Woods R.. Eye movements and reading with large print and optical magnifiers in macular disease. Optom Vis Sci 2001; 78: 325–334.
   PubMed Web of Science ®Google Scholar
• Cheong A., Lovie‐kitchin J., Bowers A.. Fixed versus individualised acuity reserve methods for determining magnification for low vision reading. Clin Exp Optom 2002; 85: 229–237.
   PubMedGoogle Scholar
• Raasch TW. What we don't know about eccentric viewing. Br J Ophthalmol 2004; 88: 443.
   Web of Science ®Google Scholar
• Rubin GS. Vision rehabilitation. In: Wormald R., Smeeth L., Henshaw K., eds. Evidence‐based Ophthalmology. London: BMJ Books; 2004. p 395–399.
   Google Scholar
• Cheong A., Lovie‐kitchin J., Bowers A., Brown B.. Short‐term reading practice improves reading performance with stand magnifiers for people with AMD. Optom Vis Sci 2005; 82: 114–127.
   PubMed Web of Science ®Google Scholar
• Whittaker SG. New approaches to vision rehabilitation. In: Fine S., Berger J., Maguire M., eds. Age‐Related Macular Degeneration. Philadelphia: Mosby, 1998.
   Google Scholar
• Hensil J., Whittaker S.. Visual reading versus auditory reading by sighted persons and persons with low vision. J Vis Impair Blindness 2000; 94: 762–771.
   Web of Science ®Google Scholar
• Lovie‐kitchin JE, Whittaker SG. Low vision assessment for reading rehabilitation: Indications for visual field assessment. In: Vision 1996, Proceedings of the International Conference on Low Vision 1996. Book I. Madrid: Organizacion Nacional de Ciegos Espanoles, 1998. p. 268–275.
   Google Scholar
• Vingrys AJ, Dwyer PS. Age‐related maculopathy with foveal sparing. Clin Exp Optom 1990; 73: 138–142.
   Google Scholar
• Whittaker SG, Lovie‐kitchin JE. Sailing with low vision. J Vis Impair Blindness 1991; 85: 205–207.
   Web of Science ®Google Scholar
• Timberlake GT, Mainster MA, Peli E., Augliere RA, Essock E., Arend LE. Reading with a macular scotoma: I. Retinal location of scotoma and fixation area. Invest Ophthalmol Vis Sci 1986; 27: 1137–1147.
   Web of Science ®Google Scholar
• Whittaker SG, Budd JM, Cummings RW. Eccentric fixation with macular scotoma. Invest Ophthalmol Vis Sci 1988; 29: 268–278.
   PubMed Web of Science ®Google Scholar
• Lovie‐kitchin JE, Mainstone J., Robinson J., Brown B.. What areas of the visual field are important for mobility in low vision patients Clin Vis Sci 1990; 4: 249–263.
   Google Scholar
• Lei H., Schuchard RA. Using two preferred retinal loci for different lighting conditions in patients with central scotomas. Invest Ophthalmol Vis Sci 1997; 38: 1812–1818.
   PubMed Web of Science ®Google Scholar
• Eldred KB. Optimal illumination for reading in patients with age‐related maculopathy. Optom Vis Sci 1992; 69: 46–50.
   PubMed Web of Science ®Google Scholar
• Bowers A., Meek C., Stewart N.. Illumination and reading performance in age‐related macular degeneration. Clin Exp Optom 2001; 84: 139–147.
   PubMedGoogle Scholar
• Sloan LL. Variation of acuity with luminance in ocular diseases and anomalies. Doc Ophthalmol 1969; 26: 384–393.
   Web of Science ®Google Scholar
• Sloan LL, Habel A., Feiock K.. High illuminations as an auxiliary reading aid in diseases of the macula. Am J Ophthalmol 1973; 76: 745–757.
   PubMed Web of Science ®Google Scholar
• Rubin GS, Bressler NM. Effects of verteporfin therapy on contrast sensitivity: Results from the Treatment of Age‐Related Macular Degeneration with Photodynamic Therapy (TAP) investigation—TAP report No 4. Retina 2002; 22: 536–544.
   PubMed Web of Science ®Google Scholar
• Bellmann C., Unnebrink K., Rubin GS, Miller D., Holz FG. Visual acuity and contrast sensitivity in patients with neovascular age‐related macular degeneration. Results from the Radiation Therapy for Age‐Related Macular Degeneration (RAD) Study. Graefe's Arch Clin Exp Ophthalmol 2003; 241: 968–974.
   PubMed Web of Science ®Google Scholar
• Barnes RM, Gee L., Taylor S., Briggs MC, Harding SP. Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation—‘beyond the TAP study’. Eye 2004; 18: 809–813.
   Web of Science ®Google Scholar
• Whittaker SG, Lovie‐kitchin JE. The assessment of contrast sensitivity and contrast reserve for reading rehabilitation. In: Kooijman AC, Looijestijn PL, Welling JA, Vanderwildt GJ, eds. Low Vision—Research and New Development in Rehabilitation. Amsterdam: IOS Press, 1994. p. 88–92.
   Google Scholar
• Lennerstrand G., Ahlstrom CO. Contrast sensitivity in macular degeneration and the relation to subjective visual impairment. Acta Ophthalmol Scand 1989; 67: 225–233.
   Google Scholar
• Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age‐related macular degeneration: a randomised controlled trial. Br J Ophthalmol 2004; 88: 1443–1449.
   PubMed Web of Science ®Google Scholar
• La Grow SJ. The effectiveness of comprehensive low vision services for older persons with visual impairments in New Zealand. J Vis Impair Blindness 2004; 98: 679–692.
   Web of Science ®Google Scholar
• Leat SJ, Rumney NJ. The experience of a university‐based low vision clinic. Ophthalmic Physiol Opt 1990; 10: 8–15.
   PubMed Web of Science ®Google Scholar
• Raasch TW, Leat SJ, Kleinstein RN, Bullimore MA, Cutter GR. Evaluating the value of low‐vision services. J Am Optom Assoc 1997; 68: 287–295.
   PubMedGoogle Scholar
• Mccabe P., Nason F., Turco Demers P., Friedman D., Seddon JM. Evaluating the effectiveness of a vision rehabilitation intervention using an objective and subjective measure of functional performance. Ophthal Epidemiol 2000; 7: 259–270.
   PubMedGoogle Scholar
• Hinds A., Sinclair A., Park J., Suttie A., Paterson H., Macdonald M.. Impact of an interdisciplinary low vision service on the quality of life of low vision patients. Br J Ophthalmol 2003; 87: 1391–1396.
   PubMed Web of Science ®Google Scholar
• Martin S., Roosevelt C., Bullimore M., Raasch T., Group LS. The development of a battery of functional tests for low vision. Optom Vis Sci 1999; 76 (Suppl): 98.
   Google Scholar
• Howe LJ. Clinical management of age‐related macular degeneration: room for improvement. Eye 1995; 9: 42–46.
   Web of Science ®Google Scholar
• Dutton GN. Age‐related macular degeneration: could we improve the services we offer Br J Ophthalmol 2000; 84: 945–946.
   Web of Science ®Google Scholar
• Rosenthal B., Thompson B.. Awareness of age‐related macular degeneration in adults: the results of a large‐scale international survey. Optometry 2003; 74: 16–24.
   PubMedGoogle Scholar